Webcast

Volpara Health Technologies Investor Briefing – 13 October

October 13, 2021

Volpara Health Technologies Investor Briefing – 13 October

Volpara Health Technologies (ASX: VHT) Webcast Replay

13th October, 2021

Volpara Health Technologies (ASX: VHT) is a fast-growing cancer diagnostics provider with a global presence and leading AI-powered tech.

As a part of our ‘The Insiders: Meet the CEOs’ series, Founder & CEO Ralph Highnam, provides valuable insights to the company, its key markets and industry, and future prospects.

Recorded on 13th October 2021 at 12pm (AEDT).

Join the next The Insider: Meet the CEOs webcast

Speak to the Reach Markets team

FEATURED SPEAKER

Ralph Highnam

Founder & CEO - Volpara Health Technologies (ASX: VHT)

Volpara is a leading provider of breast imaging analytics and analysis products that improve clinical decision-making and the early detection of breast cancer. Through recent acquisitions, the company has grown its US market share from 5% to 34% in the past five years. Further growth is predicted, with the US expected to mandate the early screening for breast cancer – a significant tailwind for Volpara’s prospects. Volpara’s tech and services are currently used in 35 countries and the company has expanded its footprint in the US$2.8 billion lung screen market.

Speak to the Reach Markets team




What is a 708 investor?

By clicking submit, I agree to the terms of the Reach Markets Financial Services Guide that includes the Privacy Statement.